Fosfomycin plus imipenem vs vancomycin
Adverse events · people with infective endocarditis due to methicillin‐resistant Staphylococcus aureus
It is very uncertain whether fosfomycin plus imipenem changes adverse events compared with vancomycin (very low certainty).
1 finding from 1 review
- A comparison of different antibiotic regimens for the treatment of infective endocarditis 2020 · Cochrane Headline outcomes onlyRR 1 [0.25, 4]1 study · 8 participantsVery low